Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression

References

• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–4.
   PubMed Web of Science ®Google Scholar
• Dexter TM, Spooncer E, Schofield R, Lord BI, Simmons P. Hematopoietic stem cells and the problem of self-renewal. Blood Cells. 1984;10:315–39.
   PubMedGoogle Scholar
• Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, . Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164:247–56.
   PubMed Web of Science ®Google Scholar
• Weng YS, Lin HY, Hsiang YJ, Hsieh CT, Li WT. The effects of different growth factors on human bone marrow stromal cells differentiating into hepatocyte-like cells. Adv Exp Med Biol. 2003;534:119–28.
   Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93–8.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331–40.
   PubMed Web of Science ®Google Scholar
• Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, . Donor origin of the in vitro hematopoietic microenvironment after marrow transplantation in man. Nature. 1982;298:280–3.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–95.
   PubMed Web of Science ®Google Scholar
• Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005;23:220–9.
   PubMed Web of Science ®Google Scholar
• Shih DT, Lee DC, Chen SC, Tsai RY, Huang CT, Tsai CC, . Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells. 2005;23:1012–20.
   Google Scholar
• In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, . Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–45.
   PubMed Web of Science ®Google Scholar
• In't Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, . Mesenchymal stem cells in human second-trimester bone marrow, liver, lung and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88:845–52.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–22.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103:4619–21.
   PubMed Web of Science ®Google Scholar
• Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, . Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84:231–7.
   PubMed Web of Science ®Google Scholar
• Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol. 1990;144:731–5.
   PubMed Web of Science ®Google Scholar
• Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, . HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol. 1999;11:889–98.
   Google Scholar
• Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, . The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes. 2006;55:1214–22.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res. 2005;65:10139–44.
   PubMed Web of Science ®Google Scholar
• Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, . Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain. 2005;128:2689–704.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N. HLA-G molecules: from maternal–fetal tolerance to tissue acceptance. Adv Immunol. 2003;81:199–252.
   PubMed Web of Science ®Google Scholar
• Colonna M, Navarro F, Bellon T, Llano M, García P, Samaridis J, . A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186:1809–18.
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, . Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 1998;160:3096–100.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 1999;189:1093–100.
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA. 1997;94:11520–5.
   PubMed Web of Science ®Google Scholar
• Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol. 2001;166:5018–26.
   PubMed Web of Science ®Google Scholar
• Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 2000;48:17–26.
   Google Scholar
• Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol. 2005;35:1133–42.
   PubMed Web of Science ®Google Scholar
• Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, . HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Human Immunol. 2000;61:1177–95.
   PubMedGoogle Scholar
• Campagnoli C, Roberts Irene AG, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396–402.
   PubMed Web of Science ®Google Scholar
• Hoogduijn MJ, Crop MJ, Peeters AMA, Van Osch GJ, Balk AH, Ijzermans JN, . Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007;16:597–604.
   PubMed Web of Science ®Google Scholar
• Cherry, Yasumizu R, Toki J, Asou H, Nishino T, Komatsu Y, . Production of hematopoietic stem cell-chemotactic factor by bone marrow stromal cells. Blood. 1994;83:964–71.
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5:485–9.
   PubMed Web of Science ®Google Scholar
• Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, . Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722–9.
   PubMed Web of Science ®Google Scholar
• Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, . Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129:118–29.
   PubMed Web of Science ®Google Scholar
• Boyson JE, Iwanaga KK, Golos TG, Watkins DI. Identification of a novel MHC class I gene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus. J Immunol. 1997;159:3311–21.
   PubMed Web of Science ®Google Scholar
• Boyson JE, Iwanaga KK, Urvater JA, Hughes AL, Golos TG, Watkins DI. Evolution of a new nonclassical MHC class I locus in two Old World primate species. Immunogenetics. 1999;49:86–98.
   PubMed Web of Science ®Google Scholar
• Comiskey M, Goldstein CY, De Fazio SR, Mammolenti M, Newmark JA, Warner CM. Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product. Human Immunol. 2003;64:999–1004.
   PubMed Web of Science ®Google Scholar
• Stroynowski I, Tabaczewski P. Multiple products of class Ib Qa-2 genes: which ones are functional? Res Immunol. 1996;147:290–301.
   Google Scholar
• Cao W, Brenner CA, Alikani M, Cohen J, Warner CM. Search for a human homologue of the mouse Ped gene. Mol Hum Reprod. 1999;5:541–7.
   Google Scholar
• Menier C, Riteau B, Carosella ED, Rouas-Freiss N. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer. 2002;100:63–70.
   PubMed Web of Science ®Google Scholar
• Creput C, Durrbach A, Menier C, Guettier C, Samuel D, Dausset J, . Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver–kidney transplantation. J Hepatol. 2003;39:587–94.
   Google Scholar
• van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, . Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod. 2007;13:123–33.
   PubMed Web of Science ®Google Scholar